BIOS Fund III QP, LP — SEC insider filings
SEC reporting owner CIK 1791916. 21 insider filings on record with FilingPulse; latest filed 2026-10-30.
Transaction summary — filings shown
Covers all 21 filings on record, filed 2021-08-03 to 2026-10-30. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 27 legs across 9 filings — 6,329,667 shares, $13,048,408 total (shares × price as filed on priced legs).
- Open-market sales (code S, non-derivative): 9 legs across 3 filings — 719,315 shares, $424,983 total (shares × price as filed on priced legs).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 120.
- Largest priced transaction: purchase of 375,000 shares @ $8.00 ($3,000,000) in ACTUATE THERAPEUTICS, INC., filed 2024-08-14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ACTUATE THERAPEUTICS, INC. (ACTU) | Director, 10% owner | 5 | 3 legs · 571,428 sh · $4,499,996 | 6 legs · 49,998 sh · $424,983 | 65 |
| IN8BIO, INC. (INAB) | 10% owner | 7 | 9 legs · 1,873,685 sh · $3,606,447 | — | 24 |
| Azitra Inc (AZTR) | 10% owner | 1 | 6 legs · 2,297,490 sh · $3,000,000 | 3 legs · 669,317 sh | 24 |
| COGNITION THERAPEUTICS INC (CGTX) | Director, 10% owner | 8 | 9 legs · 1,587,064 sh · $1,941,965 | — | 7 |
Insider filings — BIOS Fund III QP, LP
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-30 | 4 | ACTUATE THERAPEUTICS, INC. (ACTU) jointly with BIOS Fund III, LP, BIOS Fund III NT, LP | Grant/award (A): 64,995 (derivative) @ $0 · Grant/award (A): 87,743 (derivative) @ $0 · Grant/award (A): 682,885 (derivative) @ $0 · Grant/award (A): 194,984 (derivative) @ $0 · Grant/award (A): 368,304 (derivative) @ $0 · Grant/award (A): 47,972 (derivative) @ $0 · +7 more | EDGAR |
| 2025-06-30 | 4 | ACTUATE THERAPEUTICS, INC. (ACTU) jointly with Fletcher Aaron G.L., BIOS Capital Management, LP, BIOS Advisors GP, LLC, BIOS Fund III, LP, BIOS Fund III NT, LP, BIOS Actuate Co-Invest I, LP, BIOS Actuate Co-Invest II, LP, Bios Actuate Co-Invest III, LP, BIOS Equity Partners III, LP | Purchase (P): 71,428 @ $7 · Purchase (P): 71,428 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | COGNITION THERAPEUTICS INC (CGTX) jointly with Kreis Leslie W., Cavu Advisors, LLC, Cavu Management, LP, BIOS Fund II NT, LP, BIOS Memory SPV II, LP, BIOS Equity Partners III, LP, BIOS Fund III, LP, BIOS Fund III NT, LP, BP Directors, LP | Grant/award (A): 34,000 @ $0 | EDGAR |
| 2025-05-07 | 4 | IN8BIO, INC. (INAB) jointly with Kreis Leslie W., BIOS Fund III, LP, BIOS Fund III NT, LP, Bios Equity Partners II, LP, BIOS Equity Partners III, LP, BP Directors, LP, Bios Equity Partners, LP, Cavu Management, LP, Cavu Advisors, LLC | Purchase (P): 1,148,482 (derivative) · Other (J): 574,241 (derivative) · Other (J): 574,241 (derivative) | EDGAR |
| 2024-10-11 | 4 | IN8BIO, INC. (INAB) jointly with Kreis Leslie W., BIOS Fund III, LP, BIOS Fund III NT, LP, Bios Equity Partners II, LP, BIOS Equity Partners III, LP, BP Directors, LP, Bios Equity Partners, LP, Cavu Management, LP, Cavu Advisors, LLC | Purchase (P): 709,040 (derivative) · Purchase (P): 709,040 (derivative) · Disposition to issuer (D): 574,241 (derivative) · Grant/award (A): 574,241 (derivative) | EDGAR |
| 2024-08-20 | 4/A | ACTUATE THERAPEUTICS, INC. (ACTU) jointly with Fletcher Aaron G.L., BIOS Capital Management, LP, BIOS Advisors GP, LLC, BIOS Fund III, LP, BIOS Fund III NT, LP, BIOS Actuate Co-Invest I, LP, BIOS Actuate Co-Invest II, LP, Bios Actuate Co-Invest III, LP, BIOS Equity Partners III, LP | Sale (S): 5,314 @ $8 · Sale (S): 17,361 @ $8 · Sale (S): 2,324 @ $8 | EDGAR |
| 2024-08-14 | 4 | ACTUATE THERAPEUTICS, INC. (ACTU) jointly with Fletcher Aaron G.L., BIOS Capital Management, LP, BIOS Advisors GP, LLC, BIOS Fund III, LP, BIOS Fund III NT, LP, BIOS Actuate Co-Invest I, LP, BIOS Actuate Co-Invest II, LP, Bios Actuate Co-Invest III, LP, BIOS Equity Partners III, LP | Conversion (C): 884,427 · Purchase (P): 375,000 @ $8 · Purchase (P): 125,000 @ $8 · Conversion (C): 525,797 · Conversion (C): 307,538 · Conversion (C): 141,457 · +50 more | EDGAR |
| 2024-08-14 | 4 | ACTUATE THERAPEUTICS, INC. (ACTU) jointly with Fletcher Aaron G.L., BIOS Capital Management, LP, BIOS Advisors GP, LLC, BIOS Fund III, LP, BIOS Fund III NT, LP, BIOS Actuate Co-Invest I, LP, BIOS Actuate Co-Invest II, LP, Bios Actuate Co-Invest III, LP, BIOS Equity Partners III, LP | Holdings only — no transactions reported | EDGAR |
| 2024-06-11 | 4 | COGNITION THERAPEUTICS INC (CGTX) jointly with Kreis Leslie W., Cavu Advisors, LLC, Cavu Management, LP, BIOS Fund II NT, LP, BIOS Memory SPV II, LP, BIOS Equity Partners III, LP, BIOS Fund III, LP, BIOS Fund III NT, LP, BP Directors, LP | Grant/award (A): 8,500 @ $0 · Grant/award (A): 8,500 (derivative) @ $0 | EDGAR |
| 2023-12-14 | 4 | IN8BIO, INC. jointly with Fletcher Aaron G.L., BIOS Fund II, LP, BIOS Fund II QP, LP, BIOS Fund II NT, LP, BIOS Incysus Co-Invest I, LP, BIOS Fund III, LP, BIOS Fund III NT, LP, BIOS Capital Management, LP, BIOS Advisors GP, LLC | Purchase (P): 574,241 (derivative) · Purchase (P): 574,241 (derivative) · Purchase (P): 574,241 (derivative) | EDGAR |
| 2023-11-13 | 4 | COGNITION THERAPEUTICS INC (CGTX) jointly with Kreis Leslie W., Cavu Advisors, LLC, Cavu Management, LP, BIOS Fund II NT, LP, BIOS Memory SPV II, LP, BIOS Equity Partners III, LP, BIOS Fund III, LP, BIOS Fund III NT, LP, BP Directors, LP | Grant/award (A): 500,095 @ $1.05 | EDGAR |
| 2023-06-23 | 4 | Azitra Inc (AZTR) jointly with Fletcher Aaron G.L., BIOS Capital Management, LP, BIOS Advisors GP, LLC, BIOS Fund III, LP, BIOS Fund III NT, LP, BIOS Equity Partners III, LP, BIOS Azitra Co-Invest I, LP | Sale (S): 77,953 · Purchase (P): 197,701 · Purchase (P): 69,880 @ $5 · Conversion (C): 137,186 · Sale (S): 509,141 · Purchase (P): 1,291,258 · +27 more | EDGAR |
| 2023-06-13 | 4 | COGNITION THERAPEUTICS INC (CGTX) jointly with Kreis Leslie W., Cavu Advisors, LLC, Cavu Management, LP, BIOS Fund II NT, LP, BIOS Memory SPV II, LP, BIOS Equity Partners III, LP, BIOS Fund III, LP, BIOS Fund III NT, LP | Grant/award (A): 6,000 @ $0 · Grant/award (A): 6,000 (derivative) @ $0 | EDGAR |
| 2022-12-13 | 4 | IN8BIO, INC. (INAB) jointly with Fletcher Aaron G.L., BIOS Fund II, LP, BIOS Fund II QP, LP, BIOS Fund II NT, LP, BIOS Incysus Co-Invest I, LP, BIOS Fund III, LP, BIOS Fund III NT, LP, BIOS Capital Management, LP, BIOS Advisors GP, LLC | Purchase (P): 9,214 @ $2.48 · Purchase (P): 57,052 @ $2.48 · Purchase (P): 8,735 @ $2.48 | EDGAR |
| 2022-11-29 | 4 | COGNITION THERAPEUTICS INC (CGTX) jointly with Kreis Leslie W., Cavu Advisors, LLC, Cavu Management, LP, BIOS Fund II NT, LP, BIOS Memory SPV II, LP, BIOS Equity Partners III, LP, BIOS Fund III, LP, BIOS Fund III NT, LP | Purchase (P): 1,973 @ $2.65 · Purchase (P): 12,220 @ $2.65 · Purchase (P): 1,871 @ $2.65 | EDGAR |
| 2022-11-17 | 4 | COGNITION THERAPEUTICS INC (CGTX) jointly with Kreis Leslie W., Cavu Advisors, LLC, Cavu Management, LP, BIOS Fund II NT, LP, BIOS Memory SPV II, LP, BIOS Equity Partners III, LP, BIOS Fund III, LP, BIOS Fund III NT, LP | Purchase (P): 8,722 @ $1.40 · Purchase (P): 54,009 @ $1.40 · Purchase (P): 8,269 @ $1.40 | EDGAR |
| 2022-11-16 | 4 | COGNITION THERAPEUTICS INC (CGTX) jointly with Kreis Leslie W., Cavu Advisors, LLC, Cavu Management, LP, BIOS Fund II NT, LP, BIOS Memory SPV II, LP, BIOS Equity Partners III, LP, BIOS Fund III, LP, BIOS Fund III NT, LP | Purchase (P): 184,270 @ $1.20 · Purchase (P): 1,141,030 @ $1.20 · Purchase (P): 174,700 @ $1.20 | EDGAR |
| 2022-09-29 | 4 | IN8BIO, INC. (INAB) jointly with Fletcher Aaron G.L., BIOS Fund II, LP, BIOS Fund II QP, LP, BIOS Fund II NT, LP, BIOS Incysus Co-Invest I, LP, BIOS Fund III, LP, BIOS Fund III NT, LP, BIOS Capital Management, LP, BIOS Advisors GP, LLC | Purchase (P): 3,070 @ $2.02 · Purchase (P): 19,017 @ $2.02 · Purchase (P): 2,913 @ $2.02 | EDGAR |
| 2022-08-17 | 4 | IN8BIO, INC. (INAB) jointly with Kreis Leslie W., BIOS Fund II NT, LP, BIOS Fund II, LP, BIOS Incysus Co-Invest I, LP, Bios Equity Partners II, LP, BIOS Equity Partners III, LP, Cavu Management, LP, Cavu Advisors, LLC | Purchase (P): 217,891 @ $1.90 · Purchase (P): 1,349,218 @ $1.90 · Purchase (P): 206,575 @ $1.90 | EDGAR |
| 2022-02-01 | 4/A | COGNITION THERAPEUTICS INC (CGTX) jointly with BIOS Memory SPV I, LP, BIOS Fund I, LP, BIOS Fund I QP, LP, BIOS Fund II, LP, BIOS Fund II QP, LP, BIOS Fund II NT, LP, BIOS Memory SPV II, LP, BIOS Fund III, LP, BIOS Fund III NT, LP | Conversion (C): 1,424,014 | EDGAR |
| 2021-08-03 | 4 | IN8BIO, INC. (INAB) jointly with Fletcher Aaron G.L., BIOS Fund III, LP, BIOS Fund III NT, LP, BIOS Capital Management, LP, BIOS Advisors GP, LLC | Conversion (C): 574,432 · Conversion (C): 1,876,624 · Conversion (C): 251,211 · Conversion (C): 997,433 · Conversion (C): 340,712 · Conversion (C): 2,225,316 · +8 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-07-14 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1791916 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs